Skip to main content
Healthcare

STAT+: Most-favored nations policy makes drugmakers rethink launches abroad

STAT+: Most-favored nations policy makes drugmakers rethink launches abroad

Feed excerpt — reported by STAT News

Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations" policy:

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.